CIB2 p.Arg66Trp
c.196C>T · rs780168150 · VCV1064924
Computational evidence
| Protein change | ||
| AlphaMissense | 0.6759 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.262 | benign-leaning |
| SaProt | LLR -13.20 | damaging |
| ⇒ AlphaMissense and SaProt call this damaging; REVEL does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6.7 | GERP -1.1, phastCons 1 |
| Regional constraint | o/e 0.91 | unconstrained · MANE · 26 kb · p 0.17 · regional, not allelic |
| Overall | ||
| CADD | 34.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0096% | 10,413 |
| European (non-Finnish)grpmax | 0.00873% | 11,453 |
| South Asian | 0.0011% | 91,078 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CIB2
- Protein
- p.Arg66Trp
- Coding
- c.196C>T
- MANE Select
- NM_006383
- dbSNP
- rs780168150
- Type
- single nucleotide variant
- Location
- chr15:78111167 (GRCh38)
- Gene constraint
- LOEUF 1.274 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 88.71 · 1 PDB
- Residue 66
- the ef-hand 1 domain; a UniProt-annotated variant site (in dfnb48); a UniProt-annotated variant site (in dfnb48; uncertain significance; decreases interaction with tmc1 and tmc2; no loss of localization to stereocilia; does not affect atp-induced calcium release); a turn
Similar variants
- CIB2 p.Arg66Gln Uncertain significance ★★ ⚠ same residue
- CIB2 p.Arg66= Uncertain significance ★★ same residue
- CIB2 p.Asn118Asp Uncertain significance ★★ ⚠ same condition
- CIB2 p.Val75Met Uncertain significance ★★ ⚠ same condition
- CIB2 c.199-1G>A Likely pathogenic ★ same condition
- CIB2 p.Gln12Ter Likely pathogenic ★ same condition
- CIB2 p.Phe91Ser Likely pathogenic ★ same condition
- CIB2 p.Arg104Gln Conflicting classifications of pathogenicity ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cib2-p-arg66trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown